These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28960433)

  • 1. OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Chtioui H
    Hepatology; 2017 Dec; 66(6):2091. PubMed ID: 28960433
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.
    Bielen R; Moreno C; Van Vlierberghe H; Bourgeois S; Mulkay JP; Vanwolleghem T; Verlinden W; Brixco C; Decaestecker J; de Galocsy C; Janssens F; Van Overbeke L; Van Steenkiste C; D'Heygere F; Cool M; Wuyckens K; Nevens F; Robaeys G
    J Viral Hepat; 2017 Nov; 24(11):976-981. PubMed ID: 28504854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in the treatment of hepatitis C in 2016].
    Luo BF; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):175-180. PubMed ID: 28482403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Ponzetto A; Figura N
    Gastroenterology; 2018 Apr; 154(5):1549. PubMed ID: 29526731
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma.
    Yeo AE; Tanaka Y; Furuta T
    Hepatology; 2003 Jul; 38(1):267-8; author reply 268-9. PubMed ID: 12830011
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients.
    Cucchetti A; D'Amico G; Trevisani F; Morelli MC; Vitale A; Pinna AD; Cescon M;
    Dig Liver Dis; 2018 Feb; 50(2):156-162. PubMed ID: 29102521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
    Ji F; Yeo YH; Wei MT; Wei B; Dang S; Li Z; Nguyen MH
    Hepatology; 2018 Mar; 67(3):1180-1182. PubMed ID: 29194694
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma.
    Romeo R; Rumi MG; Del Ninno E; Colombo M
    Hepatology; 1997 Oct; 26(4):1077. PubMed ID: 9328339
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?
    Zeng QL; Li ZQ; Liang HX; Xu GH; Li CX; Zhang DW; Li W; Sun CY; Wang FS; Yu ZJ
    J Hepatol; 2016 Nov; 65(5):1068-1069. PubMed ID: 27476763
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus and hepatocellular carcinoma.
    Shimotohno K
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():290. PubMed ID: 7661598
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus, alcohol use disorders and hepatocellular carcinoma.
    Testino G; Leone S; Fagoonee S
    Panminerva Med; 2020 Jun; 62(2):123-124. PubMed ID: 29991208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K; Ohkawa S; Tamai S; Shimizu A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance for hepatocellular carcinoma.
    Braillon A
    Ann Intern Med; 2011 Aug; 155(4):274-5; author reply 275. PubMed ID: 21844557
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance for hepatocellular carcinoma.
    Kelley MJ
    Ann Intern Med; 2011 Aug; 155(4):274; author reply 275. PubMed ID: 21844558
    [No Abstract]   [Full Text] [Related]  

  • 15. External validation of the nomogram for individualized prediction of hepatocellular carcinoma occurrence in patients with hepatitis C virus-related compensated cirrhosis.
    Marot A; Vandenbulcke H; Knebel JF; Doerig C; Moreno C; Deltenre P
    Hepatology; 2017 Apr; 65(4):1419-1421. PubMed ID: 27737519
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
    Choi J; Lim YS
    EBioMedicine; 2017 Feb; 15():6-7. PubMed ID: 27979732
    [No Abstract]   [Full Text] [Related]  

  • 17. FPIN's clinical inquiries. Screening for hepatocellular carcinoma in patients with hepatitis C virus infection.
    Bossenbroek Fedoriw K; Rickett K
    Am Fam Physician; 2013 Mar; 87(6):online. PubMed ID: 23547582
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
    Brechot C
    Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of hepatocellular carcinoma and hepatitis C virus in Japan].
    Nakatani S; Nishiguchi S; Kuroki T; Tanaka T; Monna T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):759-63. PubMed ID: 7563871
    [No Abstract]   [Full Text] [Related]  

  • 20. Surveillance for hepatocellular carcinoma.
    Smoger SH
    Ann Intern Med; 2011 Aug; 155(4):275; author reply 275. PubMed ID: 21844560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.